Skip navigation

 Login or Register | Member Centre

GlobeInvestorGOLD Canada's most comprehensive investment tool.

 
Change Symbol: Lookup Trade Now

InterMune | Headlines

  • Vol:
  • Last Trade:
Search found 37 documents NextNext
1: InterMune Announces Pricing of $98.7 Million Public Offering of Common Stock
PR NEWSWIRE, January 20, 2010 11:44 PM

2: InterMune Announces Proposed Public Offering of Common Stock
PR NEWSWIRE, January 19, 2010 05:21 PM

3: InterMune Announces Modification to On-Going Phase 2b Study of ITMN-191 in Patients with Chronic HCV Infection
PR NEWSWIRE, November 17, 2009 08:30 AM

4: InterMune Reports Third Quarter 2009 Financial Results and Business Highlights
PR NEWSWIRE, November 5, 2009 04:00 PM

5: InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
PR NEWSWIRE, November 5, 2009 08:00 AM

6: InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF
PR NEWSWIRE, November 4, 2009 08:51 AM

7: INFORM-1 Results: Robust Antiviral Suppression Achieved with Combination of Nucleoside Analog Polymerase Inhibitor RG7128 and Protease Inhibitor RG7227
PR NEWSWIRE, November 3, 2009 08:16 AM

8: INFORM-1 Results: Robust Antiviral Suppression Achieved with Combination of Nucleoside Analog Polymerase Inhibitor RG7128 and Protease Inhibitor RG7227
PR NEWSWIRE, November 3, 2009 08:15 AM

9: InterMune to Present at Oppenheimer Conference
PR NEWSWIRE, October 29, 2009 04:01 PM

10: InterMune to Release Third Quarter Financial Results on November 5
PR NEWSWIRE, October 29, 2009 07:00 AM

NextNext
 

Search using one or more of the following options:

Symbol Lookup
 
 
  Search Tips
 
  * Can only be used when searching The Globe and Mail and newswires.

Back to top